Works matching IS 1342-1751 AND VI 21 AND IP 5 AND DT 2017


Results: 27
    1
    2
    3

    Female X-linked Alport syndrome with somatic mosaicism.

    Published in:
    Clinical & Experimental Nephrology, 2017, v. 21, n. 5, p. 877, doi. 10.1007/s10157-016-1352-y
    By:
    • Yokota, Kana;
    • Nozu, Kandai;
    • Minamikawa, Shogo;
    • Yamamura, Tomohiko;
    • Nakanishi, Keita;
    • Kaneda, Hisashi;
    • Hamada, Riku;
    • Nozu, Yoshimi;
    • Shono, Akemi;
    • Ninchoji, Takeshi;
    • Morisada, Naoya;
    • Ishimori, Shingo;
    • Fujimura, Junya;
    • Horinouchi, Tomoko;
    • Kaito, Hiroshi;
    • Nakanishi, Koichi;
    • Morioka, Ichiro;
    • Taniguchi-Ikeda, Mariko;
    • Iijima, Kazumoto
    Publication type:
    Article
    4
    5

    Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease.

    Published in:
    Clinical & Experimental Nephrology, 2017, v. 21, n. 5, p. 825, doi. 10.1007/s10157-016-1355-8
    By:
    • Ikeda, Masato;
    • Ueda, Yoshimi;
    • Maruyama, Yukio;
    • Yokoyama, Keitaro;
    • Yokoo, Takashi;
    • Joki, Nobuhiko;
    • Ando, Ryoichi;
    • Shinoda, Toshio;
    • Inaguma, Daijo;
    • Yamaka, Toshihiko;
    • Komatsu, Yasuhiro;
    • Koiwa, Fumihiko;
    • Sakaguchi, Toshifumi;
    • Negi, Shigeo;
    • Shigematsu, Takashi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis.

    Published in:
    Clinical & Experimental Nephrology, 2017, v. 21, n. 5, p. 781, doi. 10.1007/s10157-016-1373-6
    By:
    • Ribes, David;
    • Casemayou, Audrey;
    • EL Hachem, Hélène;
    • Laurent, Camille;
    • Guilbeau-Frugier, Céline;
    • Vergez, François;
    • Tavitian, Suzanne;
    • Schanstra, Joost;
    • Chauveau, Dominique;
    • Bascands, Jean-Loup;
    • Ysebaert, Loïc;
    • Faguer, Stanislas
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure.

    Published in:
    Clinical & Experimental Nephrology, 2017, v. 21, n. 5, p. 858, doi. 10.1007/s10157-016-1379-0
    By:
    • Katsumata, Mari;
    • Hirawa, Nobuhito;
    • Sumida, Koichiro;
    • Kagimoto, Minako;
    • Ehara, Yosuke;
    • Okuyama, Yuki;
    • Fujita, Megumi;
    • Fujiwara, Akira;
    • Kobayashi, Mayumi;
    • Kobayashi, Yusuke;
    • Yamamoto, Yuichiro;
    • Saka, Sanae;
    • Yatsu, Keisuke;
    • Fujikawa, Tetsuya;
    • Toya, Yoshiyuki;
    • Yasuda, Gen;
    • Tamura, Kouichi;
    • Umemura, Satoshi
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27